Revolutionizing Cancer Treatment: Predictive Biomarkers for Immunotherapy Success in Breast Cancer Unveiled

**Researchers at Johns Hopkins have developed a computational method to identify breast cancer patients who may benefit from immunotherapy.** Using quantitative systems pharmacology, they created virtual patients to test predictive biomarkers. Findings highlight that on-treatment biomarkers are more accurate than pretreatment ones, suggesting a less-invasive prediction method for treatment response.